FDA
approval
· 2024-03-21
FDA Approved: NEVIRAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for Nevirapine from Mylan Pharmaceuticals Inc., resulting in a generic Nevirapine product under the ANDA process.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NEVIRAPINE (NEVIRAPINE)